Page 19 - Read Online
P. 19
Page 12 of 13 Yesantharao et al. Plast Aesthet Res 2022;9:60 https://dx.doi.org/10.20517/2347-9264.2022.67
6. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ
2016;355:i4919. DOI PubMed PMC
7. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal
studies. BMC Med Res Methodol 2014;14:43. DOI PubMed PMC
8. Dai Tt, Jiang Zh, Li Sl, et al. Reconstruction of lymph vessel by lymphatic endothelial cells combined with polyglycolic acid scaffolds:
a pilot study. J Biotechnol 2010;150:182-9. DOI PubMed
9. Helm CL, Zisch A, Swartz MA. Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial
flow. Biotechnol Bioeng 2007;96:167-76. DOI PubMed
10. Zhang Q, Wu Y, Schaverien MV, Hanson SE, Chang EI, Butler CE. Abstract 128: engineering lymphatic vessels for secondary
lymphedema treatment. Plast Reconstr Surg Glob Open 2020;8:85-6. DOI
11. Wong AK, Schonmeyer BH, Singh P, Carlson DL, Li S, Mehrara BJ. Histologic analysis of angiogenesis and lymphangiogenesis in
acellular human dermis. Plast Reconstr Surg 2008;121:1144-52. DOI PubMed
12. Asaad M, Hanson SE. Tissue engineering strategies for cancer-related lymphedema. Tissue Eng Part A 2021;27:489-99. DOI
PubMed
13. Sung CJ, Gupta K, Wang J, Wong AK. Lymphatic tissue bioengineering for the treatment of postsurgical lymphedema. Bioengineering
(Basel) 2022;9:162. DOI PubMed PMC
14. Kolarzyk AM, Wong G, Lee E. Lymphatic tissue and organ engineering for in vitro modeling and in vivo regeneration. Cold Spring
Harb Perspect Med ;2022:a041169. DOI PubMed PMC
15. Neßbach P, Aitzetmüller MM. Translational challenges: lymph node tissue engineering. In: Duscher D, Shiffman MA, editors.
Regenerative medicine and plastic surgery. Cham: Springer International Publishing; 2019. p. 293-301. DOI
16. Campbell KT. Alginate biomaterial delivery systems for potential therapeutic lymphangiogenic applications: University of California,
Davis; 2020. Available from: https://www.proquest.com/openview/aebaf4a9446960c4819d523f3c8080fb/1?pq-
origsite=gscholar&cbl=18750&diss=y [Last accessed on 1 Nov 2022].
17. Kanapathy M, Kalaskar D, Mosahebi A, Seifalian AM. Development of a tissue-engineered lymphatic graft using nanocomposite
polymer for the treatment of secondary lymphedema. Artif Organs 2016;40:E1-11. DOI PubMed
18. Hooks JST, Bernard FC, Cruz-Acuña R, et al. Synthetic hydrogels engineered to promote collecting lymphatic vessel sprouting.
Biomaterials 2022;284:121483. DOI PubMed PMC
19. Alderfer L, Hall E, Hanjaya-Putra D. Harnessing biomaterials for lymphatic system modulation. Acta Biomater 2021;133:34-45. DOI
PubMed PMC
20. Nakayama KH, Hong G, Lee JC, et al. Aligned-braided nanofibrillar scaffold with endothelial cells enhances arteriogenesis. ACS Nano
2015;9:6900-8. DOI PubMed PMC
21. Nakayama KH, Alcazar C, Yang G, et al. Rehabilitative exercise and spatially patterned nanofibrillar scaffolds enhance vascularization
and innervation following volumetric muscle loss. NPJ Regen Med 2018;3:16. DOI PubMed PMC
22. Marelli B, Ghezzi CE, Barralet JE, Boccaccini AR, Nazhat SN. Three-dimensional mineralization of dense nanofibrillar collagen-
bioglass hybrid scaffolds. Biomacromolecules 2010;11:1470-9. DOI PubMed
23. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ Res 2003;92:801-8. DOI PubMed
24. Huang NF, Okogbaa J, Lee JC, et al. The modulation of endothelial cell morphology, function, and survival using anisotropic
nanofibrillar collagen scaffolds. Biomaterials 2013;34:4038-47. DOI PubMed PMC
25. McLaughlin SA, DeSnyder SM, Klimberg S, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast
cancer-related lymphedema, recommendations from an expert panel: part 2: preventive and therapeutic options. Ann Surg Oncol
2017;24:2827-35. DOI PubMed
26. Ogunleye AA, Nguyen DH, Lee GK. Surgical treatment of lymphedema. JAMA Surg 2020;155:522-3. DOI PubMed
27. Lai ES, Huang NF, Cooke JP, Fuller GG. Aligned nanofibrillar collagen regulates endothelial organization and migration. Regen Med
2012;7:649-61. DOI PubMed PMC
28. Shuck J, Schaverien MV, Chang EI. Discussion: nanofibrillar collagen scaffold enhances edema reduction and formation of new
lymphatic collectors after lymphedema surgery. Plast Reconstr Surg 2021;148:1394-5. DOI PubMed
29. Schaverien MV, Aldrich MB. New and emerging treatments for lymphedema. Semin Plast Surg 2018;32:48-52. DOI PubMed PMC
30. Alderfer L, Wei A, Hanjaya-Putra D. Lymphatic tissue engineering and regeneration. J Biol Eng 2018;12:32. DOI PubMed PMC
31. Sestito LF, Thomas SN. Biomaterials for modulating lymphatic function in immunoengineering. ACS Pharmacol Transl Sci
2019;2:293-310. DOI PubMed PMC
32. Nguyen D, Zaitseva TS, Zhou A, et al. Lymphatic regeneration after implantation of aligned nanofibrillar collagen scaffolds:
preliminary preclinical and clinical results. J Surg Oncol 2022;125:113-22. DOI PubMed
33. Hadamitzky C, Zaitseva TS, Bazalova-Carter M, et al. Aligned nanofibrillar collagen scaffolds - Guiding lymphangiogenesis for
treatment of acquired lymphedema. Biomaterials 2016;102:259-67. DOI PubMed PMC
34. Heloterä H, Alitalo K. The VEGF family, the inside story. Cell 2007;130:591-2. DOI PubMed
35. Nguyen DH, Zhou A, Posternak V, Rochlin DH. Nanofibrillar collagen scaffold enhances edema reduction and formation of new
lymphatic collectors after lymphedema surgery. Plast Reconstr Surg 2021;148:1382-93. DOI PubMed
36. Deptula P, Zhou A, Posternak V, He H, Nguyen D. Multimodality approach to lymphedema surgery achieves and maintains normal
limb volumes: a treatment algorithm to optimize outcomes. J Clin Med 2022;11:598. DOI PubMed PMC